These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 17200200

  • 1. Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis.
    Kel J, Oldenampsen J, Luca M, Drijfhout JW, Koning F, Nagelkerken L.
    Am J Pathol; 2007 Jan; 170(1):272-80. PubMed ID: 17200200
    [Abstract] [Full Text] [Related]

  • 2. Mannosylated PLP(139-151) induces peptide-specific tolerance to experimental autoimmune encephalomyelitis.
    Luca ME, Kel JM, van Rijs W, Wouter Drijfhout J, Koning F, Nagelkerken L.
    J Neuroimmunol; 2005 Mar; 160(1-2):178-87. PubMed ID: 15710471
    [Abstract] [Full Text] [Related]

  • 3. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH, Bourdette DN, Hashim GA, Herndon RM, Ilg RC, Vandenbark AA, Offner H.
    J Immunol; 1991 Jan 01; 146(1):101-7. PubMed ID: 1701788
    [Abstract] [Full Text] [Related]

  • 4. Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen.
    Carrizosa AM, Nicholson LB, Farzan M, Southwood S, Sette A, Sobel RA, Kuchroo VK.
    J Immunol; 1998 Oct 01; 161(7):3307-14. PubMed ID: 9759846
    [Abstract] [Full Text] [Related]

  • 5. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.
    Elliott EA, McFarland HI, Nye SH, Cofiell R, Wilson TM, Wilkins JA, Squinto SP, Matis LA, Mueller JP.
    J Clin Invest; 1996 Oct 01; 98(7):1602-12. PubMed ID: 8833909
    [Abstract] [Full Text] [Related]

  • 6. FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration.
    Kataoka H, Sugahara K, Shimano K, Teshima K, Koyama M, Fukunari A, Chiba K.
    Cell Mol Immunol; 2005 Dec 01; 2(6):439-48. PubMed ID: 16426494
    [Abstract] [Full Text] [Related]

  • 7. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
    Jung EJ, Hur M, Kim YL, Lee GH, Kim J, Kim I, Lee M, Han HK, Kim MS, Hwang S, Kim S, Woo AM, Yoon Y, Park HJ, Won J.
    J Pharmacol Exp Ther; 2009 Dec 01; 331(3):1005-13. PubMed ID: 19741152
    [Abstract] [Full Text] [Related]

  • 8. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire.
    Kuchroo VK, Anderson AC, Waldner H, Munder M, Bettelli E, Nicholson LB.
    Annu Rev Immunol; 2002 Dec 01; 20():101-23. PubMed ID: 11861599
    [Abstract] [Full Text] [Related]

  • 9. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N, Mendel I, Ben-Nun A.
    Eur J Immunol; 1995 Apr 01; 25(4):985-93. PubMed ID: 7737302
    [Abstract] [Full Text] [Related]

  • 10. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
    Takács K, Chandler P, Altmann DM.
    Eur J Immunol; 1997 Nov 01; 27(11):2927-34. PubMed ID: 9394820
    [Abstract] [Full Text] [Related]

  • 11. Delineation of the minimal encephalitogenic epitope of proteolipid protein peptide(91-110) and critical residues required for induction of EAE in HLA-DR3 transgenic mice.
    Mangalam AK, Khare M, Krco CJ, Rodriguez M, David CS.
    J Neuroimmunol; 2005 Apr 01; 161(1-2):40-8. PubMed ID: 15748942
    [Abstract] [Full Text] [Related]

  • 12. Prevention of murine EAE by oral hydrolytic enzyme treatment.
    Targoni OS, Tary-Lehmann M, Lehmann PV.
    J Autoimmun; 1999 May 01; 12(3):191-8. PubMed ID: 10222028
    [Abstract] [Full Text] [Related]

  • 13. Characterization of proteolipid protein-peptide-specific CD(4)(+) T cell of experimental allergic encephalomyelitis in Biozzi AB/H mice.
    Peng Y, Liu CP.
    Chin Med J (Engl); 2002 Apr 01; 115(4):521-4. PubMed ID: 12133288
    [Abstract] [Full Text] [Related]

  • 14. Mycobacterium smegmatis expressing a chimeric protein MPT64-proteolipid protein (PLP) 139-151 reorganizes the PLP-specific T cell repertoire favoring a CD8-mediated response and induces a relapsing experimental autoimmune encephalomyelitis.
    Nicolò C, Sali M, Di Sante G, Geloso MC, Signori E, Penitente R, Uniyal S, Rinaldi M, Ingrosso L, Fazio VM, Chan BM, Delogu G, Ria F.
    J Immunol; 2010 Jan 01; 184(1):222-35. PubMed ID: 19949067
    [Abstract] [Full Text] [Related]

  • 15. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein.
    Greer JM, Sobel RA, Sette A, Southwood S, Lees MB, Kuchroo VK.
    J Immunol; 1996 Jan 01; 156(1):371-9. PubMed ID: 8598487
    [Abstract] [Full Text] [Related]

  • 16. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
    Imler TJ, Petro TM.
    Int Immunopharmacol; 2009 Jan 01; 9(1):134-43. PubMed ID: 19022403
    [Abstract] [Full Text] [Related]

  • 17. Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M).
    Kaushansky N, Eisenstein M, Oved JH, Ben-Nun A.
    Int Immunol; 2008 Nov 01; 20(11):1439-49. PubMed ID: 18801757
    [Abstract] [Full Text] [Related]

  • 18. Encephalitogenicity of complete Freund's adjuvant relative to CpG is linked to induction of Th17 cells.
    Tigno-Aranjuez JT, Jaini R, Tuohy VK, Lehmann PV, Tary-Lehmann M.
    J Immunol; 2009 Nov 01; 183(9):5654-61. PubMed ID: 19812193
    [Abstract] [Full Text] [Related]

  • 19. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides.
    Whitham RH, Kotzin BL, Buenafe AC, Weinberg AD, Jones RE, Hashim GA, Hoy CM, Vandenbark AA, Offner H.
    J Neurosci Res; 1993 Jun 01; 35(2):115-28. PubMed ID: 7686583
    [Abstract] [Full Text] [Related]

  • 20. Mannosylated self-peptide inhibits the development of experimental autoimmune encephalomyelitis via expansion of nonencephalitogenic T cells.
    Kel JM, Slütter B, Drijfhout JW, Koning F, Nagelkerken L.
    J Leukoc Biol; 2008 Jul 01; 84(1):182-90. PubMed ID: 18424662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.